2026年全球癌症现状报告：我们共同选择的未来

The future we choose together Global status reporton cancer 2026The future we choose together Global status report on cancer 2026: the future we choose together ISBN 978-92-4-012397-7 (electronic version)ISBN 978-92-4-012398-4 (print version) © World Health Organization 2026 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0IGO licence (CCBY-NC-SA3.0IGO;https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes,provided the work is appropriately cited, as indicated below. In any use of this work, there should be nosuggestion that WHO endorses any specific organization, products or services. The use of the WHO logois not permitted. If you adapt the work, then you must license your work under the same or equivalentCreative Commons licence. If you create a translation of this work, you should add the following disclaimeralong with the suggested citation:“This translation was not created by the World Health Organization(WHO). WHO is not responsible for the content or accuracy of this translation. The original English editionshall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with themediation rules of the World Intellectual Property Organization (http://www.wipo.int/amc/en/mediation/rules/). Suggested citation. Global status report on cancer 2026: the future we choose together. Geneva: WorldHealth Organization; 2026. Licence:CCBY-NC-SA3.0IGO. Cataloguing-in-Publication (CIP) data.CIP data are available athttp://iris.who.int. Sales, rights and licensing.To purchase WHO publications, seehttps://www.who.int/publications/book-orders. To submit requests for commercial use and queries on rights and licensing, seehttps://www.who.int/copyright. Third-party materials.If you wish to reuse material from this work that is attributed to a third party, suchas tables, figures or images, it is your responsibility to determine whether permission is needed for thatreuse and to obtain permission from the copyright holder. The risk of claims resulting from infringementof any third-party-owned component in the work rests solely with the user. General disclaimers.The designations employed and the presentation of the material in this publicationdo not imply the expression of any opinion whatsoever on the part of WHO concerning the legal statusof any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers orboundaries. Dotted and dashed lines on maps represent approximate border lines for which there maynot yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they areendorsed or recommended by WHO in preference to others of a similar nature that are not mentioned.Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication.However, the published material is being distributed without warranty of any kind, either expressed orimplied. The responsibility for the interpretation and use of the material lies with the reader. In no eventshall WHO be liable for damages arising from its use. Design and layout: Inis Communication Contents Foreword from the IARC Directorvi Acknowledgementsvii Abbreviationsxii Executive summaryxiv 1 Introduction1 1.1 A critical juncture for cancer control11.2 A critical measure for health systems41.3 A critical focus on inequity and on listening to people affected51.4 Scope and purpose of this report5 2 The global cancer burden: what we know from the data and from the peopleaffected7 2.1 Global cancer incidence rates82.2 Global cancer mortality rates and survival112.3 Tracking SDG 3.4: premature mortality from NCDs212.4 Trends: current drivers and future projections262.5 Capturing the lived experience of people affected by cancer382.6 Cancer’s financial burden and economic costs, for health systems and societies54 3 Status update: progress made and key gaps in implementation57 3.1 Risk factors and prevention583.2 Early detection823.3 Treatment1073.4 Supportive, palliative care and survivorship care123 4 What drives success, what slows our progress: global alignment andsystemic challenges 4.1 Monitoring and evaluating our progress together1354.2 Global leadership, translated into integrated action1414.3 National transition from strategies to implementation1784.4 Individual and community level priorities198 5 A future we choose together: better capabilities, better protections,better value 5.1 Redefining success: ending cancer’s identity crisis2055.2 Three shifts: better capabilities, better protections, better value2085.3 Seven recommendations: shared actions for a shared futu